Salivary, but not serum or urinary levels of progesterone are elevated after topical application of progesterone cream to pre- and postmenopausal women

Clinical Endocrinology

Volumn 53, Issue 5, 2000, Pages 615-620

  O'Leary, P ^a   Feddema, P ^a   Chan, K ^a   Taranto, M ^a   Smith, M ^a   Evans, S ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG USE; FEMALE; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROGESTERONE URINE LEVEL; SALIVA LEVEL;

ABSORPTION; ADMINISTRATION, TOPICAL; FEMALE; HUMANS; LUTEAL PHASE; MIDDLE AGED; POSTMENOPAUSE; PREMENOPAUSE; PROGESTERONE; SALIVA;

EID: 0033730174     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2000.01130.x     Document Type: Article

References (32)

1. Effet in vivo de l'administration locale de progesterone sur l'activite mitotique des galactophores humains. Resultat d'une etude pilote
2. Hormonal treatment of postmenopausal women
3. Assessment of bioavailability of oral micronised progesterone using a salivary progesterone enzymeimmunoassay
4. Influences of percutaneous administration of oestradiol and progesterone on human breast epithelial cell cycle in vivo
5. Prevention and treatment of osteoporosis with hormone replacement therapy
6. Systemic absorption of progesterone from Progest cream in postmenopausal women
7. Steroid concentrations in serum, glandular breast tissue, and breast cyst fluid of control and P-treated patients
8. 24-Hour profiles of salivary progesterone
9. Human erythrocyte membrane. Uptake of progesterone and chemical alterations
10. Human endometrial cells in primary tissue culture: Modulation of the progesterone receptor level by natural and synthetic oestrogens in vitro
11. Permeation of steroids through human skin
12. Validations of time-resolved fluoroimmunoassays for urinary estrone-3-glucuronide and pregnanediol-3-glucuronide
13. Pharmacokinetics of ooestrogens and progestogens
14. Dose dependent effects of oral progesterone on the ooestrogenised postmenopausal endometrium
15. Use of Pro-Gest cream in postmenopausal women
16. Metabolic clearance of progesterone in the menstrual cycle
17. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure
18. Oral administration of micronised progesterone: A review and more experience
19. Improved HPLC method for simultaneous analysis of cortisol, 11-deoxycortisol, prednisolone, methylprednisolone, and dexamethasone in serum and urine
20. Indices of ovulation: Comparison of plasma and salivary levels of progesterone with urinary pregnanediol
21. Incidence of ovulation in young women
22. Relationship of serum oestradiol and progesterone concentrations to the excretion profiles of their major urinary metabolites as measured by enzyme immunoassay and radioimmunoassay
23. Incidence of breast cancer in a 22-year study of women receiving oestrogen-progestin replacement therapy
24. Plasma levels of progesterone after vaginal, rectal or intramuscular administration of progesterone
25. Endometrial disease after treatment with ooestrogens and progestogens in the climacteric
26. Progesterone as a bone-trophic hormone
27. Hormone replacement therapy and cardiovascular disease
28. The metabolic and cardiovascular consequences of HRT
29. Direct solid-phase enzyme immunoassay of progesterone in saliva
30. Micronised transdermal progesterone and endometrial response
31. Non-oral administration of progesterone: Experiences and possibilities of the transvaginal route